Literature DB >> 24599356

[An unusual cause of apparent oligoarthritis. A step back and a second look].

C Fiehn1, C Goerke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599356     DOI: 10.1007/s00393-013-1316-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  5 in total

1.  The importance of whole body imaging in tumor-induced osteomalacia.

Authors:  William H Chong; Sahzene Yavuz; Shrita M Patel; Clara C Chen; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2011-12       Impact factor: 5.958

2.  Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.

Authors:  Anne E Nelson; Roderick Clifton Bligh; Michiko Mirams; Anthony Gill; Amy Au; Adele Clarkson; Harald Jüppner; Stephen Ruff; Paul Stalley; Richard A Scolyer; Bruce G Robinson; Rebecca S Mason; Phillip Clifton Bligh
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

3.  Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.

Authors:  David E Leaf; Renata C Pereira; Hasan Bazari; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

4.  Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

Authors:  Itsuro Endo; Seiji Fukumoto; Keiichi Ozono; Noriyuki Namba; Hiroyuki Tanaka; Daisuke Inoue; Masanori Minagawa; Toshitsugu Sugimoto; Mika Yamauchi; Toshimi Michigami; Toshio Matsumoto
Journal:  Bone       Date:  2008-03-05       Impact factor: 4.398

5.  Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.

Authors:  M Woznowski; I Quack; J Stegbauer; N Büchner; L C Rump; G Schieren
Journal:  Clin Nephrol       Date:  2008-11       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.